Clearmind Medicine Inc. (CMND)

NASDAQ: CMND · Real-Time Price · USD

0.7150

-0.0008 (-0.11%)

At close: Oct 2, 2026, 4:00 PM EDT

0.7446

+0.0296 (4.14%)

After-hours: Oct 2, 2026, 7:49 PM EDT

Clearmind Medicine Balance Sheet

Financials in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 31, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Cash & Equivalents	12.04	3.92	6.57	5.43	0.13	3.71
Short-Term Investments	3.89	1.66	0.29	0.09	0.19	-
Cash & Short-Term Investments	15.93	5.59	6.86	5.51	0.32	3.71
Cash Growth	355.59%	-18.62%	24.47%	1609.58%	-91.31%	1396.58%
Other Receivables	0.59	0.32	0.18	0.24	0.1	0.13
Receivables	0.59	0.32	0.18	0.24	0.1	0.13
Prepaid Expenses	0.1	0.04	0.04	0.04	0.01	0.13
Total Current Assets	16.63	5.95	7.09	5.79	0.43	3.97
Property, Plant & Equipment	0.18	0.02	0.05	0	0.05	0.02
Other Intangible Assets	0.09	0.1	0.11	0.12	0.13	0.16
Long-Term Deferred Charges	-	-	-	-	0.2	-
Other Long-Term Assets	0.02	0.02	0.01	0.04	0.01	0.02
Total Assets	16.91	6.08	7.26	5.95	0.83	4.16

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 31, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Accounts Payable	0.72	0.68	0.53	0.62	1.4	0.28
Accrued Expenses	0.07	0.06	0.05	0.04	0.21	0.01
Current Portion of Long-Term Debt	1.62	1.76	-	-	-	-
Current Portion of Leases	0.07	0.02	0.04	-	0.04	-
Other Current Liabilities	1.37	2.37	3.52	4.31	0.29	-
Total Current Liabilities	3.86	4.89	4.13	4.97	1.93	0.29
Long-Term Leases	0.1	-	0.02	-	-	-
Total Liabilities	3.96	4.89	4.15	4.97	1.93	0.29

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 31, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Common Stock	45.03	26.4	24.17	17.13	6.71	6.38
Retained Earnings	-34.69	-27.88	-24.02	-18.77	-10.15	-3.58
Comprehensive Income & Other	2.61	2.67	2.96	2.62	2.33	1.08
Shareholders' Equity	12.95	1.19	3.11	0.98	-1.11	3.87
Total Liabilities & Equity	16.91	6.08	7.26	5.95	0.83	4.16

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 31, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Total Debt	1.8	1.78	0.05	-	0.04	-
Net Cash (Debt)	14.13	3.81	6.81	5.51	0.28	3.71
Net Cash Growth	307.47%	-44.10%	23.51%	1840.56%	-92.34%	1396.58%
Net Cash Per Share	27.90	299.52	-	-	-	-
Filing Date Shares Outstanding	3.37	0.02	0.01	-	-	-
Total Common Shares Outstanding	2.15	0.02	0.01	-	-	-
Working Capital	12.77	1.06	2.96	0.82	-1.5	3.68
Book Value Per Share	6.04	75.44	291.43	-	-	-
Tangible Book Value	12.86	1.1	3	0.86	-1.24	3.71
Tangible Book Value Per Share	6.00	69.28	281.27	-	-	-
Machinery	-	-	-	-	-	0.02

SEC Filings: 10-K · 10-Q